within Pharmacolibrary.Drugs.ATC.B;

model B02BD05
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 5e-05,
    adminDuration  = 600,
    adminMass      = 90 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00019,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00028000000000000003,
    k12             = 3.7,
    k21             = 3.7
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>B02BD05</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Coagulation factor VII (recombinant activated factor VII, rFVIIa) is a protein used to promote hemostasis in patients with hemophilia A or B with inhibitors to factor VIII or IX, as well as in other rare bleeding disorders. It is approved for use in bleeding episodes and surgical interventions to aid in blood clotting.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adults following a single intravenous dose of recombinant activated factor VII (rFVIIa).</p><h4>References</h4><ol><li><p>Watt, BE, et al., &amp; Vale, JA (2005). Anticoagulant rodenticides. <i>Toxicological reviews</i> 24(4) 259–269. DOI:<a href=&quot;https://doi.org/10.2165/00139709-200524040-00005&quot;>10.2165/00139709-200524040-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16499407/&quot;>https://pubmed.ncbi.nlm.nih.gov/16499407</a></p></li><li><p>Villar, A, et al., &amp; Giangrande, PL (2004). Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A. <i>Haemophilia : the official journal of the World Federation of Hemophilia</i> 10(4) 352–359. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2516.2004.00925.x&quot;>10.1111/j.1365-2516.2004.00925.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15230949/&quot;>https://pubmed.ncbi.nlm.nih.gov/15230949</a></p></li><li><p>Björkman, S, &amp; Berntorp, E (2001). Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia. <i>Clinical pharmacokinetics</i> 40(11) 815–832. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200140110-00003&quot;>10.2165/00003088-200140110-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11735604/&quot;>https://pubmed.ncbi.nlm.nih.gov/11735604</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end B02BD05;
